{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:02:27Z","timestamp":1793908947994,"version":"4.8.0"},"reference-count":132,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23DK128651"],"award-info":[{"award-number":["K23DK128651"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01 HX003091"],"award-info":[{"award-number":["I01 HX003091"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Kidney Disease and Health"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1053\/j.akdh.2022.12.004","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T08:20:38Z","timestamp":1677658838000},"page":"164-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Breaking the Cycle of Recurrent Calcium Stone Disease"],"prefix":"10.1053","volume":"30","author":[{"given":"Deepa A.","family":"Malieckal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calyani","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4225-6197","authenticated-orcid":false,"given":"Denisse Arellano","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8589-9083","authenticated-orcid":false,"given":"Alan C.","family":"Pao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1053\/j.akdh.2022.12.004_bib1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/ki.2012.419","article-title":"Emergency department visits, use of imaging, and drugs for urolithiasis have increased in the United States","volume":"83","author":"Fwu","year":"2013","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.004_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.mayocp.2018.12.014","article-title":"Prediction tool to predict symptomatic kidney stone episodes: a step toward personalizing kidney stone care","volume":"94","author":"Hsi","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1053\/j.akdh.2022.12.004_bib3","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1046\/j.1523-1755.2003.00917.x","article-title":"Time trends in reported prevalence of kidney stones in the United States: 1976-1994","volume":"63","author":"Stamatelou","year":"2003","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.004_bib4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.eururo.2012.03.052","article-title":"Prevalence of kidney stones in the United States","volume":"62","author":"Scales","year":"2012","journal-title":"Eur Urol"},{"issue":"9","key":"10.1053\/j.akdh.2022.12.004_bib5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrneph.2016.101","article-title":"Idiopathic hypercalciuria and formation of calcium renal stones","volume":"12","author":"Coe","year":"2016","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2022.12.004_bib6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1172\/JCI17038","article-title":"Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle","volume":"111","author":"Evan","year":"2003","journal-title":"The Journal of clinical investigation"},{"issue":"5","key":"10.1053\/j.akdh.2022.12.004_bib7","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.juro.2016.04.086","article-title":"Topography, composition and structure of incipient Randall plaque at the Nanoscale level","volume":"196","author":"Verrier","year":"2016","journal-title":"J Urol"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.004_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.ju.0000147270.68481.ce","article-title":"Stone formation is proportional to papillary surface coverage by Randall's plaque","volume":"173","author":"Kim","year":"2005","journal-title":"J Urol"},{"issue":"6","key":"10.1053\/j.akdh.2022.12.004_bib9","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1046\/j.1523-1755.2003.00316.x","article-title":"Urine calcium and volume predict coverage of renal papilla by Randall's plaque","volume":"64","author":"Kuo","year":"2003","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.akdh.2022.12.004_bib10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1089\/end.2000.14.507","article-title":"Metabolic and urinary risk factors associated with Randall's papillary plaques","volume":"14","author":"Low","year":"2000","journal-title":"J Endourol"},{"issue":"10","key":"10.1053\/j.akdh.2022.12.004_bib11","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000566","article-title":"Demographics and characterization of 10,282 Randall plaque-related kidney stones: a new epidemic? Medicine (Baltimore)","volume":"94","author":"Letavernier","year":"2015","journal-title":"Medicine"},{"issue":"10","key":"10.1053\/j.akdh.2022.12.004_bib12","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2215\/CJN.01490214","article-title":"Distinguishing characteristics of idiopathic calcium oxalate kidney stone formers with low amounts of Randall's plaque","volume":"9","author":"Wang","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.akdh.2022.12.004_bib13","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.2215\/CJN.11321210","article-title":"Pathophysiology-based treatment of idiopathic calcium kidney stones","volume":"6","author":"Coe","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2022.12.004_bib14","doi-asserted-by":"crossref","first-page":"F1236","DOI":"10.1152\/ajprenal.00035.2018","article-title":"Randall's plaque in stone formers originates in ascending thin limbs","volume":"315","author":"Evan","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.004_bib15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/bju.13555","article-title":"The origins of urinary stone disease: upstream mineral formations initiate downstream Randall's plaque","volume":"119","author":"Hsi","year":"2017","journal-title":"BJU Int"},{"issue":"4","key":"10.1053\/j.akdh.2022.12.004_bib16","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0022-5347(01)65565-4","article-title":"High resolution radiography of cadaveric kidneys: unraveling the mystery of Randall's plaque formation","volume":"156","author":"Stoller","year":"1996","journal-title":"J Urol"},{"issue":"Pt D","key":"10.1053\/j.akdh.2022.12.004_bib17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ijsu.2016.11.020","article-title":"The role of the 24-h urine collection in the management of nephrolithiasis","volume":"36","author":"Ennis","year":"2016","journal-title":"Int J Surg"},{"issue":"9507","key":"10.1053\/j.akdh.2022.12.004_bib18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0140-6736(06)68071-9","article-title":"Kidney stones: pathophysiology and medical management","volume":"367","author":"Moe","year":"2006","journal-title":"Lancet"},{"key":"10.1053\/j.akdh.2022.12.004_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.urology.2020.05.064","article-title":"The association between 24-hour urine and stone recurrence among high risk kidney stone formers: a population level assessment","volume":"144","author":"Samson","year":"2020","journal-title":"Urology"},{"key":"10.1053\/j.akdh.2022.12.004_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.urology.2020.11.054","article-title":"Comparison of selective versus empiric pharmacologic preventative therapy with kidney stone recurrence","volume":"149","author":"Hsi","year":"2021","journal-title":"Urology"},{"key":"10.1053\/j.akdh.2022.12.004_bib21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.urology.2021.12.037","article-title":"Comparison of selective vs empiric pharmacologic preventive therapy of kidney stone recurrence with high-risk Features","volume":"164","author":"Hsi","year":"2022","journal-title":"Urology"},{"issue":"4","key":"10.1053\/j.akdh.2022.12.004_bib22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1046\/j.1464-410x.1999.00216.x","article-title":"A prospective study of nonmedical prophylaxis after a first kidney stone","volume":"84","author":"Kocvara","year":"1999","journal-title":"BJU Int"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.004_bib23","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.juro.2014.05.006","article-title":"Medical management of kidney stones: AUA guideline","volume":"192","author":"Pearle","year":"2014","journal-title":"J Urol"},{"issue":"9","key":"10.1053\/j.akdh.2022.12.004_bib24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.7326\/M13-2908","article-title":"Clinical guidelines committee of the American college of P. dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American college of physicians","volume":"161","author":"Qaseem","year":"2014","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1053\/j.akdh.2022.12.004_bib25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41581-021-00513-4","article-title":"The genetics of kidney stone disease and nephrocalcinosis","volume":"18","author":"Singh","year":"2022","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.004_bib26","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.mayocp.2018.09.016","article-title":"Predictors of symptomatic kidney stone recurrence after the first and subsequent Episodes","volume":"94","author":"Vaughan","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"10.1053\/j.akdh.2022.12.004_bib27","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1681\/ASN.V8101568","article-title":"Family history and risk of kidney stones","volume":"8","author":"Curhan","year":"1997","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.akdh.2022.12.004_bib28","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ekir.2018.11.017","article-title":"A twin study of genetic Influences on nephrolithiasis in women and men","volume":"4","author":"Goldfarb","year":"2019","journal-title":"Kidney Int Rep"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.004_bib29","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1681\/ASN.2016050576","article-title":"Progress in Understanding the genetics of calcium-containing nephrolithiasis","volume":"28","author":"Sayer","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2022.12.004_bib30","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.kint.2017.06.020","article-title":"A population-based approach to assess the heritability and distribution of renal handling of electrolytes","volume":"92","author":"Moulin","year":"2017","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.004_bib31","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.kint.2017.06.025","article-title":"Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and nephrocalcinosis","volume":"93","author":"Daga","year":"2018","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.akdh.2022.12.004_bib32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41585-020-0332-x","article-title":"Genetics of kidney stone disease","volume":"17","author":"Howles","year":"2020","journal-title":"Nat Rev Urol"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.004_bib33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00240-016-0945-y","article-title":"Tubular and genetic disorders associated with kidney stones","volume":"45","author":"Mohebbi","year":"2017","journal-title":"Urolithiasis"},{"issue":"9","key":"10.1053\/j.akdh.2022.12.004_bib34","doi-asserted-by":"crossref","first-page":"659","DOI":"10.7326\/M13-2908","article-title":"Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American college of physicians","volume":"161","author":"Qaseem","year":"2014","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.004_bib35","doi-asserted-by":"crossref","first-page":"36","DOI":"10.7326\/0003-4819-93-1-36","article-title":"Evidence justifying a high fluid intake in treatment of nephrolithiasis","volume":"93","author":"Pak","year":"1980","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.004_bib36","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0022-5347(01)66321-3","article-title":"Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study","volume":"155","author":"Borghi","year":"1996","journal-title":"J Urol"},{"issue":"8","key":"10.1053\/j.akdh.2022.12.004_bib37","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/archinte.164.8.885","article-title":"Dietary factors and the risk of incident kidney stones in younger women: nurses' health study II","volume":"164","author":"Curhan","year":"2004","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1053\/j.akdh.2022.12.004_bib38","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1056\/NEJM199303253281203","article-title":"A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones","volume":"328","author":"Curhan","year":"1993","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1053\/j.akdh.2022.12.004_bib39","doi-asserted-by":"crossref","first-page":"497","DOI":"10.7326\/0003-4819-126-7-199704010-00001","article-title":"Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women","volume":"126","author":"Curhan","year":"1997","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.004_bib40","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s00240-006-0040-x","article-title":"The effect of calcium channel blockers on stone regrowth and recurrence after shock wave lithotripsy","volume":"34","author":"Sarica","year":"2006","journal-title":"Urol Res"},{"issue":"6","key":"10.1053\/j.akdh.2022.12.004_bib41","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0022-5347(17)51711-5","article-title":"The stone clinic effect in patients with idiopathic calcium urolithiasis","volume":"130","author":"Hosking","year":"1983","journal-title":"J Urol"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.004_bib42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0002-9343(82)90566-6","article-title":"Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective study","volume":"72","author":"Strauss","year":"1982","journal-title":"Am J Med"},{"issue":"6","key":"10.1053\/j.akdh.2022.12.004_bib43","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1053\/j.ajkd.2020.09.016","article-title":"Prevention of urinary stones with hydration (PUSH): design and rationale of a clinical trial","volume":"77","author":"Scales","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.akdh.2022.12.004_bib44","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/sj.ki.5002708","article-title":"24-h uric acid excretion and the risk of kidney stones","volume":"73","author":"Curhan","year":"2008","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.004_bib45","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJMoa010369","article-title":"Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria","volume":"346","author":"Borghi","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.004_bib46","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000166901","article-title":"Influence of the calcium content of the diet on the incidence of mild hyperoxaluria in idiopathic renal stone formers","volume":"5","author":"Jaeger","year":"1985","journal-title":"Am J Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.004_bib47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0002-9343(82)90567-8","article-title":"Effects of low-calcium diet on urine calcium excretion, parathyroid function and serum 1,25(OH)2D3 levels in patients with idiopathic hypercalciuria and in normal subjects","volume":"72","author":"Coe","year":"1982","journal-title":"Am J Med"},{"issue":"4","key":"10.1053\/j.akdh.2022.12.004_bib48","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ki.2010.473","article-title":"Nephrolithiasis-associated bone disease: pathogenesis and treatment options","volume":"79","author":"Sakhaee","year":"2011","journal-title":"Kidney Int"},{"issue":"10","key":"10.1053\/j.akdh.2022.12.004_bib49","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.2215\/CJN.01520216","article-title":"Dietary protein and potassium, diet-Dependent net acid load, and risk of incident kidney stones","volume":"11","author":"Ferraro","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2022.12.004_bib50","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0021-9681(79)90107-3","article-title":"Dietary changes and the incidence of urinary calculi in the U.K. between 1958 and 1976","volume":"32","author":"Robertson","year":"1979","journal-title":"J Chronic Dis"},{"issue":"5","key":"10.1053\/j.akdh.2022.12.004_bib51","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.kint.2019.02.003","article-title":"Effect of thiazolidinedione therapy on the risk of uric acid stones","volume":"95","author":"Asplin","year":"2019","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.004_bib52","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1210\/jcem-66-1-140","article-title":"Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism","volume":"66","author":"Breslau","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1053\/j.akdh.2022.12.004_bib53","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1464-410X.1979.tb03570.x","article-title":"Should recurrent calcium oxalate stone formers become vegetarians?","volume":"51","author":"Robertson","year":"1979","journal-title":"Br J Urol"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.004_bib54","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.juro.2014.01.093","article-title":"Animal protein and the risk of kidney stones: a comparative metabolic study of animal protein sources","volume":"192","author":"Tracy","year":"2014","journal-title":"J Urol"},{"issue":"7","key":"10.1053\/j.akdh.2022.12.004_bib55","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2215\/CJN.11741111","article-title":"Comparative effects of low-carbohydrate high-protein versus low-fat diets on the kidney","volume":"7","author":"Friedman","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1053\/j.akdh.2022.12.004_bib56","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1210\/jc.2011-1531","article-title":"Hypercalciuria associated with high dietary protein intake is not due to acid load","volume":"96","author":"Maalouf","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.004_bib57","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1053\/ajkd.2002.34504","article-title":"Effect of low-carbohydrate high-protein diets on acid-base balance, stone-forming propensity, and calcium metabolism","volume":"40","author":"Reddy","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.004_bib58","doi-asserted-by":"crossref","first-page":"e485","DOI":"10.1210\/clinem\/dgaa759","article-title":"Hypercalcemia in children using the ketogenic diet: a multicenter study","volume":"106","author":"Hawkes","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1-2","key":"10.1053\/j.akdh.2022.12.004_bib59","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s004670000443","article-title":"Risk factors for urolithiasis in children on the ketogenic diet","volume":"15","author":"Furth","year":"2000","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.004_bib60","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/diseases9020039","article-title":"Incidence and characteristics of kidney stones in patients on ketogenic diet: a systematic review and Meta-analysis","volume":"9","author":"Acharya","year":"2021","journal-title":"Diseases"},{"issue":"5","key":"10.1053\/j.akdh.2022.12.004_bib61","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1056\/NEJM198501313120505","article-title":"Paleolithic nutrition. A consideration of its nature and current implications","volume":"312","author":"Eaton","year":"1985","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1053\/j.akdh.2022.12.004_bib62","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.3390\/nu13124270","article-title":"The relationship between modern Fad diets and kidney stone disease: a systematic review of literature","volume":"13","author":"Barghouthy","year":"2021","journal-title":"Nutrients"},{"issue":"5","key":"10.1053\/j.akdh.2022.12.004_bib63","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/ajcn\/nqaa066","article-title":"Mediterranean diet adherence and risk of incident kidney stones","volume":"111","author":"Rodriguez","year":"2020","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.akdh.2022.12.004_bib64","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/00365515909060464","article-title":"Effect of chlorothiazide and hydrochlorothiazide on the excretion of calcium in urine","volume":"11","author":"Lamberg","year":"1959","journal-title":"Scand J Clin Lab Invest"},{"issue":"6","key":"10.1053\/j.akdh.2022.12.004_bib65","first-page":"614","article-title":"The use of thiazides in the prevention of renal calculi","volume":"102","author":"Yendt","year":"1970","journal-title":"Can Med Assoc J"},{"issue":"11","key":"10.1053\/j.akdh.2022.12.004_bib66","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nrneph.2011.138","article-title":"The mechanism of hypocalciuria with NaCl cotransporter inhibition","volume":"7","author":"Reilly","year":"2011","journal-title":"Nat Rev Nephrol"},{"issue":"10","key":"10.1053\/j.akdh.2022.12.004_bib67","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.2215\/CJN.04670510","article-title":"The evidence-based use of thiazide diuretics in hypertension and nephrolithiasis","volume":"5","author":"Reilly","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.akdh.2022.12.004_bib68","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00240-013-0568-5","article-title":"Hydrochlorothiazide compared to chlorthalidone in reduction of urinary calcium in patients with kidney stones","volume":"41","author":"Wolfgram","year":"2013","journal-title":"Urolithiasis"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.004_bib69","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s12882-018-1144-6","article-title":"Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trial","volume":"19","author":"Dhayat","year":"2018","journal-title":"BMC Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.004_bib70","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s11255-010-9824-6","article-title":"Thiazides diuretics in the treatment of nephrolithiasis: are we using them in an evidence-based fashion?","volume":"43","author":"Vigen","year":"2011","journal-title":"Int Urol Nephrol"},{"issue":"7","key":"10.1053\/j.akdh.2022.12.004_bib71","doi-asserted-by":"crossref","first-page":"535","DOI":"10.7326\/0003-4819-158-7-201304020-00005","article-title":"Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American college of physicians clinical guideline","volume":"158","author":"Fink","year":"2013","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.004_bib72","first-page":"134","article-title":"Hypocitraturia: pathophysiology and medical management","volume":"11","author":"Zuckerman","year":"2009","journal-title":"Rev Urol"},{"key":"10.1053\/j.akdh.2022.12.004_bib73","series-title":"Hydrochlorothiazide for the Prevention of Kidney Stone Recurrence [Abstract]","author":"Fuster","year":"2022"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.004_bib74","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/ki.1986.201","article-title":"Successful management of uric acid nephrolithiasis with potassium citrate","volume":"30","author":"Pak","year":"1986","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.004_bib75","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0002-9343(80)90495-7","article-title":"Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria","volume":"69","author":"Pak","year":"1980","journal-title":"Am J Med"},{"issue":"4","key":"10.1053\/j.akdh.2022.12.004_bib76","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/ki.1990.265","article-title":"Renal handling of citrate","volume":"38","author":"Hamm","year":"1990","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.004_bib77","first-page":"F223","article-title":"Citrate excretion: a window on renal metabolism","volume":"244","author":"Simpson","year":"1983","journal-title":"Am J Physiol"},{"issue":"Suppl 16","key":"10.1053\/j.akdh.2022.12.004_bib78","first-page":"S49","article-title":"Low urinary citrate: an overview","volume":"23","author":"Zacchia","year":"2010","journal-title":"J Nephrol"},{"issue":"33","key":"10.1053\/j.akdh.2022.12.004_bib79","doi-asserted-by":"crossref","first-page":"20972","DOI":"10.1074\/jbc.273.33.20972","article-title":"Characterization of a rat Na+-dicarboxylate cotransporter","volume":"273","author":"Chen","year":"1998","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1053\/j.akdh.2022.12.004_bib80","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.1074\/jbc.270.11.5779","article-title":"Sequence and functional characterization of a renal sodium\/dicarboxylate cotransporter","volume":"270","author":"Pajor","year":"1995","journal-title":"J Biol Chem"},{"issue":"4 Pt 2","key":"10.1053\/j.akdh.2022.12.004_bib81","first-page":"F642","article-title":"Molecular cloning and functional expression of a sodium-dicarboxylate cotransporter from human kidney","volume":"270","author":"Pajor","year":"1996","journal-title":"Am J Physiol"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.004_bib82","doi-asserted-by":"crossref","first-page":"F482","DOI":"10.1152\/ajprenal.2000.279.3.F482","article-title":"Molecular cloning, chromosomal organization, and functional characterization of a sodium-dicarboxylate cotransporter from mouse kidney","volume":"279","author":"Pajor","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.004_bib83","first-page":"F298","article-title":"Cloning, functional characterization, and localization of a rat renal Na+-dicarboxylate transporter","volume":"275","author":"Sekine","year":"1998","journal-title":"Am J Physiol"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.004_bib84","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1046\/j.1523-1755.2000.00155.x","article-title":"Chronic metabolic acidosis increases NaDC-1 mRNA and protein abundance in rat kidney","volume":"58","author":"Aruga","year":"2000","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.akdh.2022.12.004_bib85","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/ki.1995.171","article-title":"Trade-offs in the adaptation to acidosis","volume":"47","author":"Alpern","year":"1995","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.004_bib86","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.kint.2020.07.006","article-title":"Spot urinary citrate-to-creatinine ratio is a marker for acid-base status in chronic kidney disease","volume":"99","author":"Gianella","year":"2021","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.akdh.2022.12.004_bib87","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.2215\/CJN.00560112","article-title":"A woman with recurrent calcium phosphate kidney stones","volume":"7","author":"Goldfarb","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2022.12.004_bib88","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.kint.2018.11.033","article-title":"Urine citrate excretion as a marker of acid retention in patients with chronic kidney disease without overt metabolic acidosis","volume":"95","author":"Goraya","year":"2019","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.004_bib89","doi-asserted-by":"crossref","first-page":"F502","DOI":"10.1152\/ajprenal.00044.2019","article-title":"Urine citrate excretion identifies changes in acid retention as eGFR declines in patients with chronic kidney disease","volume":"317","author":"Goraya","year":"2019","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"10.1053\/j.akdh.2022.12.004_bib90","doi-asserted-by":"crossref","first-page":"F623","DOI":"10.1152\/ajprenal.00494.2017","article-title":"Mechanism for higher urine pH in normal women compared with men","volume":"314","author":"Worcester","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"10.1053\/j.akdh.2022.12.004_bib91","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0022-5347(17)35888-3","article-title":"Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis","volume":"150","author":"Barcelo","year":"1993","journal-title":"J Urol"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.004_bib92","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0022-5347(17)46962-X","article-title":"Long-term treatment of calcium nephrolithiasis with potassium citrate","volume":"134","author":"Pak","year":"1985","journal-title":"J Urol"},{"issue":"6","key":"10.1053\/j.akdh.2022.12.004_bib93","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/S0022-5347(01)68155-2","article-title":"Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis","volume":"158","author":"Ettinger","year":"1997","journal-title":"J Urol"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.004_bib94","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.urology.2013.03.002","article-title":"The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers","volume":"82","author":"Pinheiro","year":"2013","journal-title":"Urology"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.004_bib95","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.juro.2015.10.082","article-title":"Medication Nonadherence and effectiveness of preventive pharmacological therapy for kidney stones","volume":"195","author":"Dauw","year":"2016","journal-title":"J Urol"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.004_bib96","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/003655900750016869","article-title":"Long-term follow-up of stone formers treated with a low dose of sodium potassium citrate","volume":"34","author":"Jendle-Bengten","year":"2000","journal-title":"Scand J Urol Nephrol"},{"key":"10.1053\/j.akdh.2022.12.004_bib97","doi-asserted-by":"crossref","first-page":"i52","DOI":"10.1136\/bmj.i52","article-title":"Medical management of renal stones","volume":"352","author":"Morgan","year":"2016","journal-title":"BMJ"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.004_bib98","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00240-018-1090-6","article-title":"Empiric therapy for kidney stones","volume":"47","author":"Goldfarb","year":"2019","journal-title":"Urolithiasis"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.004_bib99","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1089\/end.2022.0274","article-title":"Alkali citrate content of common over-the-counter and medical food Supplements","volume":"37","author":"Dai","year":"2022","journal-title":"J Endourol"},{"key":"10.1053\/j.akdh.2022.12.004_bib100","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.urology.2022.05.049","article-title":"Over-the-Counter alkali Agents to raise urine pH and citrate excretion: a prospective crossover study in healthy adults","volume":"168","author":"Canvasser","year":"2022","journal-title":"Urology"},{"issue":"6","key":"10.1053\/j.akdh.2022.12.004_bib101","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1089\/end.2008.0069","article-title":"Assessment of citrate concentrations in citrus fruit-based juices and beverages: implications for management of hypocitraturic nephrolithiasis","volume":"22","author":"Haleblian","year":"2008","journal-title":"J Endourol"},{"issue":"6","key":"10.1053\/j.akdh.2022.12.004_bib102","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.juro.2010.02.2388","article-title":"Citrate, malate and alkali content in commonly consumed diet sodas: implications for nephrolithiasis treatment","volume":"183","author":"Eisner","year":"2010","journal-title":"J Urol"},{"issue":"10","key":"10.1053\/j.akdh.2022.12.004_bib103","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1089\/end.2020.0031","article-title":"Using low-calorie orange juice as a dietary alternative to alkali therapy","volume":"34","author":"Large","year":"2020","journal-title":"J Endourol"},{"issue":"22","key":"10.1053\/j.akdh.2022.12.004_bib104","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1056\/NEJM198611273152204","article-title":"Randomized trial of allopurinol in the prevention of calcium oxalate calculi","volume":"315","author":"Ettinger","year":"1986","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1053\/j.akdh.2022.12.004_bib105","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1681\/ASN.2007020219","article-title":"Oxalate intake and the risk for nephrolithiasis","volume":"18","author":"Taylor","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.004_bib106","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/MOU.0000000000000709","article-title":"Future treatments for hyperoxaluria","volume":"30","author":"Burns","year":"2020","journal-title":"Curr Opin Urol"},{"issue":"8","key":"10.1053\/j.akdh.2022.12.004_bib107","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrneph.2012.113","article-title":"An update on primary hyperoxaluria","volume":"8","author":"Hoppe","year":"2012","journal-title":"Nat Rev Nephrol"},{"issue":"10","key":"10.1053\/j.akdh.2022.12.004_bib108","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1681\/ASN.2014070698","article-title":"Phenotype-genotype correlations and estimated carrier frequencies of primary hyperoxaluria","volume":"26","author":"Hopp","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.004_bib109","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000030323","article-title":"Oral calcium supplement decreases urinary oxalate excretion in patients with enteric hyperoxaluria","volume":"61","author":"Takei","year":"1998","journal-title":"Urol Int"},{"issue":"5","key":"10.1053\/j.akdh.2022.12.004_bib110","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.surg.2010.11.015","article-title":"Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery","volume":"149","author":"Kumar","year":"2011","journal-title":"Surgery"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.004_bib111","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2215\/CJN.08000520","article-title":"Pathophysiology and treatment of enteric hyperoxaluria","volume":"16","author":"Witting","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.004_bib112","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3109\/00365528009181482","article-title":"Calcium treatment of enteric hyperoxaluria after jejunoileal bypass for morbid obesity","volume":"15","author":"Hylander","year":"1980","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.004_bib113","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41585-021-00543-4","article-title":"Perspectives in primary hyperoxaluria \u2014 historical, current and future clinical interventions","volume":"19","author":"Shee","year":"2022","journal-title":"Nat Rev Urol"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.004_bib114","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000448766","article-title":"A double-blind, placebo controlled, randomized phase 1 Cross-over study with ALLN-177, an orally administered oxalate degrading enzyme","volume":"44","author":"Langman","year":"2016","journal-title":"Am J Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2022.12.004_bib115","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/ndt\/gfaa379","article-title":"Pilot study of reloxaliase in patients with severe enteric hyperoxaluria and hyperoxalemia","volume":"36","author":"Pfau","year":"2021","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1053\/j.akdh.2022.12.004_bib116","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100053","article-title":"Randomized placebo-controlled trial of reloxaliase in enteric hyperoxaluria","volume":"1","author":"Lieske","year":"2022","journal-title":"NEJM Evidence"},{"issue":"11","key":"10.1053\/j.akdh.2022.12.004_bib117","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.34067\/KID.0001522020","article-title":"A prospective, double-blind, randomized, placebo-controlled, crossover study using an orally administered oxalate decarboxylase (OxDC)","volume":"1","author":"Quintero","year":"2020","journal-title":"Kidney360"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.004_bib118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00446731","article-title":"Oxalobacter formigenes gen. nov., sp. nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract","volume":"141","author":"Allison","year":"1985","journal-title":"Arch Microbiol"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.004_bib119","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1464-410X.2008.08122.x","article-title":"A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease","volume":"103","author":"Siva","year":"2009","journal-title":"BJU Int"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.004_bib120","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1681\/ASN.2016020132","article-title":"Oxalobacter formigenes-Derived Bioactive factors stimulate oxalate transport by intestinal epithelial cells","volume":"28","author":"Arvans","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2022.12.004_bib121","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1681\/ASN.2007101058","article-title":"Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones","volume":"19","author":"Kaufman","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 14","key":"10.1053\/j.akdh.2022.12.004_bib122","first-page":"S334","article-title":"Direct correlation between hyperoxaluria\/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy","volume":"10","author":"Sidhu","year":"1999","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2022.12.004_bib123","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/ki.2013.104","article-title":"The role of Oxalobacter formigenes colonization in calcium oxalate stone disease","volume":"83","author":"Siener","year":"2013","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.akdh.2022.12.004_bib124","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00467-016-3553-8","article-title":"A randomised Phase I\/II trial to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria","volume":"32","author":"Hoppe","year":"2017","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"10.1053\/j.akdh.2022.12.004_bib125","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1093\/ndt\/gfr107","article-title":"Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria","volume":"26","author":"Hoppe","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1053\/j.akdh.2022.12.004_bib126","doi-asserted-by":"crossref","DOI":"10.1128\/mSystems.00088-17","article-title":"The Induction of oxalate metabolism in\u00a0vivo is more effective with functional microbial communities than with functional microbial species","volume":"2","author":"Miller","year":"2017","journal-title":"mSystems"},{"issue":"1","key":"10.1053\/j.akdh.2022.12.004_bib127","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.kint.2019.03.020","article-title":"Gut microbiome and kidney stone disease: not just an Oxalobacter story","volume":"96","author":"Ticinesi","year":"2019","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.akdh.2022.12.004_bib128","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1523-1755.2005.00520.x","article-title":"Use of a probiotic to decrease enteric hyperoxaluria","volume":"68","author":"Lieske","year":"2005","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.akdh.2022.12.004_bib129","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2215\/CJN.00600207","article-title":"A randomized, controlled trial of Lactic acid bacteria for idiopathic hyperoxaluria","volume":"2","author":"Goldfarb","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2022.12.004_bib130","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1681\/ASN.2016030338","article-title":"An investigational RNAi therapeutic targeting glycolate oxidase reduces oxalate production in models of primary hyperoxaluria","volume":"28","author":"Liebow","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"13","key":"10.1053\/j.akdh.2022.12.004_bib131","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa2021712","article-title":"Lumasiran, an RNAi therapeutic for primary hyperoxaluria type 1","volume":"384","author":"Garrelfs","year":"2021","journal-title":"N Engl J Med"},{"issue":"Pt D","key":"10.1053\/j.akdh.2022.12.004_bib132","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ijsu.2016.11.027","article-title":"RNA interference in the treatment of renal stone disease: current status and future potentials","volume":"36","author":"Wood","year":"2016","journal-title":"Int J Surg"}],"container-title":["Advances in Kidney Disease and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813922000295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813922000295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T15:40:21Z","timestamp":1757432421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949813922000295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":132,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2949813922000295"],"URL":"https:\/\/doi.org\/10.1053\/j.akdh.2022.12.004","relation":{},"ISSN":["2949-8139"],"issn-type":[{"value":"2949-8139","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breaking the Cycle of Recurrent Calcium Stone Disease","name":"articletitle","label":"Article Title"},{"value":"Advances in Kidney Disease and Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.akdh.2022.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}